Predisposition to psoriasis is known to be affected by genetic variation in HLA-C, IL12B, and IL23R, and although other psoriasis-associated variants have been identified, incontrovertible statistical evidence for these markers has not yet been obtained. To help resolve this issue, we tested 15 single-nucleotide polymorphisms (SNPs) from 7 putative psoriasis-risk genes in 1,448 psoriasis patients and 1,385 control subjects; 3 SNPs, rs597980 in ADAM33, rs6908425 in CDKAL1 and rs3789604 in PTPN22, were significant with the same risk allele as in prior reports (one-sided P<0.05, false discovery rate<0.15). These three markers were tested in a fourth sample set (599 cases and 299 controls); one marker, rs597980, replicated (one-sided P<0.05) and the other two had odds ratios with the same directionality as in the original sample sets. Mantel-Haenszel meta-analyses of all available case-control data, including those published by other groups, showed that these three markers were highly significant (rs597980: P=0.0057 (2,025 cases and 1,597 controls), rs6908425: P=1.57 x 10(-5) (3,206 cases and 4,529 controls), and rs3789604: P=3.45 x 10(-5) (2,823 cases and 4,066 controls)). These data increase the likelihood that ADAM33, CDKAL1, and PTPN22 are true psoriasis-risk genes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130997 | PMC |
| http://dx.doi.org/10.1038/jid.2008.297 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Validation of TYK2 and exploration of PRSS36 as drug targets for psoriasis using Mendelian randomization.
Sci Rep
October 2024
School of Public Health, Wannan Medical College, No. 22, Wenchang West Road, Yijiang District, Wuhu, Anhui, China.
Article Synopsis
- Psoriasis is a chronic skin condition influenced by genetic and environmental factors, highlighting the need for new treatment targets despite existing therapies.
- A Mendelian randomization analysis identified 81 potential drug targets for psoriasis, with TYK2 and PRSS36 emerging as significant candidates through colocalization analysis.
- Molecular docking studies indicated that these targets are biologically linked to immune functions and showed strong interactions with drugs, with TYK2 being validated for clinical use while PRSS36 requires more research.
Spatial distribution of residential environment, genetic susceptibility, and psoriasis: A prospective cohort study.
J Glob Health
August 2024
Shenzhen Center for Chronic Disease Control, Shenzhen Institute of Dermatology, Shenzhen City, Guangdong Province, China.
Background: Genetic and environmental factors contribute to psoriasis, but the impact of residential environments on this condition remains uncertain. We aimed to investigate the association of residential environments with psoriasis risk and explore its interaction with genes.
Methods: We retrieved data on the spatial distribution of residential environments at 300 and 1000 m buffer zones from the UK Biobank, including the proportions of natural environments, domestic gardens, green spaces, and blue spaces within these zones.
Selenium and Arsenic Levels, Prevalence of Common Variants of Genes Involved in Their Metabolism, and Psoriasis Disease.
Biomedicines
May 2024
Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, 71-252 Szczecin, Poland.
Article Synopsis
- A study measured selenium and arsenic levels in blood and serum from 336 psoriatic patients and 336 healthy controls to explore links with psoriasis severity.
- Results showed significantly lower selenium levels in patients, particularly in those with severe cases, while arsenic levels did not differ notably between the two groups.
- The findings suggest that low selenium levels are associated with higher psoriasis risk, indicating a need for further research on selenium supplementation as a potential treatment strategy.
Functional Genomics and Insights into the Pathogenesis and Treatment of Psoriasis.
Biomolecules
May 2024
Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester M6 8HD, UK.
Psoriasis is a lifelong, systemic, immune mediated inflammatory skin condition, affecting 1-3% of the world's population, with an impact on quality of life similar to diseases like cancer or diabetes. Genetics are the single largest risk factor in psoriasis, with Genome-Wide Association (GWAS) studies showing that many psoriasis risk genes lie along the IL-23/Th17 axis. Potential psoriasis risk genes determined through GWAS can be annotated and characterised using functional genomics, allowing the identification of novel drug targets and the repurposing of existing drugs.
View Article and Find Full Text PDFGenetic Study of Psoriasis Highlights its Close Link with Socioeconomic Status and Affective Symptoms.
J Invest Dermatol
December 2024
Systems epidemiology, Research Unit of Population Health, Faculty of Medicine, University of Oulu and Biocenter Oulu, Oulu, Finland.
Article Synopsis
- Psoriasis is a skin disease with about 70% heritability, and a large study with 925,649 individuals was conducted to identify genetic risk factors.
- Researchers found 6 new risk loci linked to the NF-κB signaling pathway and immunity, highlighting correlations between psoriasis and factors like smoking, body weight, and education level.
- The study also uncovered causal relationships between psoriasis and mood symptoms, as well as a reciprocal effect with lower education, which could inform future treatment strategies.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!